Skip to content

Real world study on the treatment of covid-19 with traditional Chinese medicine

Real world study on the treatment of covid-19 with traditional Chinese medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052291
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-10-21
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Traditional Chinese Medicine Comprehensive Rehabilitation Group:Traditional Chinese Medicine + Baduanjin
Natural Rehabilitation Group:None

Sponsors

People's Hospital of Shijiazhuang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with new coronary pneumonia and asymptomatic infection who have been discharged from hospital; 2. Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe disturbance of consciousness, dementia or some diseases that affect the evaluation of curative effect, such as aphasia, audio-visual impairment; 2. Those who cannot cooperate with rehabilitation assessment; 3. Patients who are judged by the investigator to be unsuitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;Lung CT;TCM symptom scale score;

Secondary

MeasureTime frame
Dyspnea index scale;Borg conscious fatigue scale;Six minute walk test;Generalized anxiety disorder scale;Berg balance scale;Tinetti gait and balance scale;Inflammatory index;Blood biochemistry index;Gastrointestinal microecology;Nerve conduction study;

Countries

China

Contacts

Public ContactYubin Zhao

People's Hospital of Shijiazhuang

drzhyubin@163.com+86 19932101717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026